Business Context and Reporting Period
This Form 6-K filing by Xiaobai Maimai Inc. (Akso Health Group) covers the month of October 2021, specifically dated October 19, 2021. The report discloses a material change in executive management and corporate governance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure regarding personnel changes and does not contain financial statements.
Material Changes
- Resignation of CEO and Chairman: On October 18, 2021, Mr. Xiaobo An resigned from his positions as Chief Executive Officer and Chairman of the Board. The resignation was not due to any disagreement with the Company.
- Role Transition: Mr. An was simultaneously appointed as Vice President and will continue to lead the Company's e-commerce business.
- Appointment of New Leadership: Ms. Yilin (Linda) Wang, previously Co-CEO, was appointed as the sole CEO and new Chairwoman of the Board to fill the vacancies.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or specific risk factors beyond the operational impact of the leadership transition. Management commentary is limited to the confirmation that the leadership change was amicable and the immediate succession plan.
Key Facts for Investor Verification
- Verify the effective date of the leadership transition (October 18, 2021).
- Confirm the new reporting structure with Ms. Wang as sole CEO and Chairwoman.
- Assess the strategic implications of Mr. An's continued role in leading the e-commerce business as Vice President.
- Check for subsequent filings regarding the Board composition or any further executive changes.